Getting healthcare innovation paid for, and to market.
A senior, partner-led advisory firm guiding pharmaceutical, medical device, and clinical diagnostic companies — and the investors who back them — through reimbursement, market access, and due diligence.
Three disciplines, one continuum.
Engaged individually or end-to-end — from first-in-class coding strategy to investor-grade diligence.
Coding & Reimbursement Support
Securing the right codes, coverage, and payment pathways so products get reimbursed.
Market Access
Payer strategy, pricing, evidence, and access planning to launch and scale.
Due Diligence
Reimbursement and commercial diligence for VCs, PE sponsors, and investment banks.
Boutique by design. Senior at every seat.
Deep reimbursement expertise
Decades inside coding, coverage, and payment — across CMS, commercial payers, and PBMs.
Partner-led, every engagement
You work directly with senior practitioners — never handed to a junior team.
Across pharma, device, and clinical diagnostics
Pattern recognition across modalities, from LDTs to durable devices to specialty therapeutics.
Investor-grade rigor
Diligence and strategy work trusted by VC, PE, and investment banking teams.
Outcomes that move products forward.
Kent McKinney
Founder & Principal
Kent founded Wellguidant Advisors to bring senior, specialized reimbursement counsel to companies and investors navigating healthcare's most consequential commercialization decisions.
About the firm →Let's discuss your reimbursement and access strategy.
Senior, partner-led engagements. Confidential by default.